Scientists are excitedly focused on retatrutide, a innovative medication from Eli Lilly, as a significant step in weight loss . Distinct from many earlier approaches, retatrutide is a dual -action agonist targeting equally GLP-1 and GIP, chemicals that impact satiety and glucose balance. Initial